Long-Term Vesicular Monoamine Transporter II Imaging and Clinical Assessment of Parkinson's Disease Progression

NCT01556100 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Parkinson Disease

Interventions

DRUG: 18F-DTBZ AV-133

Sponsor

Chang Gung Memorial Hospital